PMC:7647877 / 16818-17134 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T103","span":{"begin":149,"end":156},"obj":"Disease"},{"id":"T104","span":{"begin":218,"end":228},"obj":"Disease"},{"id":"T105","span":{"begin":255,"end":263},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].\nPersonalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T263","span":{"begin":97,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":" modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].\nPersonalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T29","span":{"begin":149,"end":156},"obj":"Phenotype"}],"attributes":[{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0001513"}],"text":" modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].\nPersonalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T86","span":{"begin":10,"end":32},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T87","span":{"begin":38,"end":62},"obj":"http://purl.obolibrary.org/obo/GO_0002250"},{"id":"T88","span":{"begin":47,"end":62},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":" modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].\nPersonalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti"}

{"project":"LitCovid-sentences","denotations":[{"id":"T101","span":{"begin":102,"end":273},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].\nPersonalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti"}

{"project":"LitCovid-PubTator","denotations":[{"id":"510","span":{"begin":79,"end":86},"obj":"Species"},{"id":"522","span":{"begin":135,"end":143},"obj":"Species"},{"id":"523","span":{"begin":264,"end":272},"obj":"Species"},{"id":"524","span":{"begin":149,"end":156},"obj":"Disease"},{"id":"525","span":{"begin":218,"end":228},"obj":"Disease"},{"id":"526","span":{"begin":255,"end":263},"obj":"Disease"}],"attributes":[{"id":"A510","pred":"tao:has_database_id","subj":"510","obj":"Tax:9606"},{"id":"A522","pred":"tao:has_database_id","subj":"522","obj":"Tax:9606"},{"id":"A523","pred":"tao:has_database_id","subj":"523","obj":"Tax:9606"},{"id":"A524","pred":"tao:has_database_id","subj":"524","obj":"MESH:D009765"},{"id":"A525","pred":"tao:has_database_id","subj":"525","obj":"MESH:D007239"},{"id":"A526","pred":"tao:has_database_id","subj":"526","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" modulate inflammatory responses, the acquired immune response, and to improve patient outcomes [34].\nPersonalized immunonutrition for patients with obesity should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patients. That therapeutic strategy could be effecti"}